ストックスクリーナーアプリを入手
29.38
3.23%
-0.98
アフターアワーズ：
29.38
前日終値:
$30.36
開ける：
$30.15
24時間の取引高:
250.70K
Relative Volume:
1.03
時価総額：
$1.92B
収益：
$1.21B
当期純損益:
$570.23M
株価収益率:
3.3937
EPS:
8.6571
ネットキャッシュフロー:
$-293.03M
1週間 パフォーマンス:
+2.91%
1か月 パフォーマンス:
-1.08%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$29.30
$30.19
1週間の範囲:
$28.60
$32.41
52週間の値動き範囲:
$25.68
$32.41
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Company Profile
Compare LKFT vs VRTX, REGN, MRNA, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LKFT
Lakefront Biotherapeutics Nv Adr
|
29.38 | 1.92B | 1.21B | 570.23M | -293.03M | 8.6571 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lakefront Biotherapeutics Nv Adr (LKFT) 最新ニュース
Crude Oil Gains 1%; Cintas Earnings Top Views - Benzinga
TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday - Benzinga
This Editas Medicine Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Benzinga
RBC upgrades Lakefront Biotherapeutics stock rating on autoimmune drug potential - Investing.com India
Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and AgomAb Therapeutics NV ADR (AGMB) - The Globe and Mail
Belite Bio, Inc. Sponsored ADR (BLTE)'s Technical Outlook is Bright After Key Golden Cross - finance.yahoo.com
TD Cowen upgrades Lakefront Biotherapeutics stock rating to buy By Investing.com - Investing.com UK
TD Cowen upgrades Lakefront Biotherapeutics stock rating to buy - Investing.com
Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA) - theglobeandmail.com
argenx SE (ARGX) Stock Price, News, Quote & History - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Dogwood Therapeutics (DWTX), Talphera (TLPH) and 4D Molecular Therapeutics (FDMT) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR) - The Globe and Mail
Grifols, S.A. (GRFS) stock price, news, quote and history - Yahoo Finance UK
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), BrightSpring Health Services, Inc. (BTSG) and AgomAb Therapeutics NV ADR (AGMB) - The Globe and Mail
argenx SE (ARGX) stock price, news, quote and history - Yahoo Finance UK
Lakefront Biotherapeutics director resigns for Sanofi role By Investing.com - Investing.com Nigeria
Lakefront Biotherapeutics director resigns for Sanofi role - Investing.com
Lakefront Biotherapeutics stock coverage resumed at Equalweight by Morgan Stanley - Investing.com Nigeria
Galapagos Q1 2026 presentation: Ouro deal, rebranding highlight transformation - Investing.com
LKFTLakefront Biotherapeutics NV ADR Latest SEC Filings - Finviz
GXEA Forecast — Price Target — Prediction for 2027 - TradingView
Form 13G Lakefront Biotherapeutics NV For: 23 June By Investing.com - Investing.com South Africa
Gilead and Lakefront complete Ouro Medicines acquisition - Investing.com
Lakefront Biotherapeutics Shares Drop as LKFT Gets Reevaluated - Bez Kabli
LKFT.AS Stock Price, Quote & Chart | LAKEFRONT BIOTHERAPEUTICS (AMS:LKFT) - ChartMill
Lakefront Receives Transparency Notification from Bank of America - Yahoo Finance Australia
LKFT Technical Analysis | Trend, Signals & Chart Patterns | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
LKFT Stock Chart | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
What is the current Price Target and Forecast for Lakefront BiotherapeuticsSponsored ADR (LKFT) - Zacks Investment Research
Earnings call transcript: Galapagos NV sees 91% revenue drop in Q1 2026 - Investing.com
LKFT: Lakefront BiotherapeuticsSponsored ADRCash Flow Statements - Zacks Investment Research
LKFT : Lakefront BiotherapeuticsSponsored Adr Key Company Details - Zacks Investment Research
Lakefront BiotherapeuticsSponsored ADR (LKFT) Return On Equity (TTM) - Zacks Investment Research
Lakefront Biotherapeutics NV Stock Baskets - GuruFocus
Lakefront Biotherapeutics (NASDAQ: GLPG) outlines ADR deposit terms - Stock Titan
LKFT Stock Price and Chart — NASDAQ:LKFT - TradingView
LKFT Stock Price and Chart — EURONEXT:LKFT - TradingView
Earnings call transcript: Galapagos Q1 2026 beats EPS, revenue falls short - Investing.com
Galapagos (GLPG) posts Q1 2026 profit and commits up to €790M to Ouro deal - Stock Titan
UpgradesStock ScreenerSnapshot - Finviz
Galapagos NV (GLPG) Stock Price, News & Analysis - Stock Titan
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
symbol__ Stock Quote Price and Forecast - CNN
ActivePassive International Equity ETF Holdings - Quiver Quantitative
Lakefront Biotherapeutics Nv Adr (LKFT) 財務データ
収益
当期純利益
現金流量
EPS
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):